Interestingly, and similarly to what occurs in patients with MADD and in Etfdh−/− mice, alterations in COQ9 have been associated with dysfunctions in CI + III and CII + CIII activity, leading to myopathies61,62. The gene discussed is ETFDH; the disease is multiple acyl-CoA dehydrogenase deficiency.